Yu‐Ching Lin

3.9k total citations
147 papers, 2.7k citations indexed

About

Yu‐Ching Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yu‐Ching Lin has authored 147 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Yu‐Ching Lin's work include Lung Cancer Treatments and Mutations (16 papers), Obstructive Sleep Apnea Research (9 papers) and Air Quality and Health Impacts (9 papers). Yu‐Ching Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Obstructive Sleep Apnea Research (9 papers) and Air Quality and Health Impacts (9 papers). Yu‐Ching Lin collaborates with scholars based in Taiwan, Japan and United States. Yu‐Ching Lin's co-authors include Liang You, David M. Jablons, Zhidong Xu, Biao He, Ying‐Huang Tsai, Chieh‐Mo Lin, Josephine Chou, Jae Kim, Cheng‐Ta Yang and Su‐Lun Hwang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Applied Physics Letters.

In The Last Decade

Yu‐Ching Lin

142 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ching Lin Taiwan 28 823 325 300 276 250 147 2.7k
Jane Lee United States 34 876 1.1× 275 0.8× 300 1.0× 235 0.9× 297 1.2× 154 3.7k
Xin Zhang China 33 894 1.1× 332 1.0× 390 1.3× 343 1.2× 248 1.0× 301 4.7k
Xiangyu Ma China 30 743 0.9× 220 0.7× 363 1.2× 159 0.6× 163 0.7× 132 2.8k
Bing Zhang China 36 796 1.0× 517 1.6× 117 0.4× 259 0.9× 119 0.5× 269 4.3k
Tōru Takeuchi Japan 41 769 0.9× 332 1.0× 232 0.8× 140 0.5× 860 3.4× 395 6.0k
Takashi Iizuka Japan 34 1.3k 1.5× 335 1.0× 106 0.4× 242 0.9× 124 0.5× 243 3.9k
Matthew Ryan Smith United States 31 703 0.9× 628 1.9× 562 1.9× 130 0.5× 275 1.1× 125 2.9k
Chengcheng Hu United States 35 693 0.8× 308 0.9× 303 1.0× 191 0.7× 53 0.2× 173 4.2k
Zhi Wang China 30 1.1k 1.3× 376 1.2× 202 0.7× 278 1.0× 61 0.2× 227 3.2k
Hong Kim United States 29 967 1.2× 183 0.6× 295 1.0× 160 0.6× 65 0.3× 129 2.9k

Countries citing papers authored by Yu‐Ching Lin

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ching Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ching Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ching Lin more than expected).

Fields of papers citing papers by Yu‐Ching Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ching Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ching Lin. The network helps show where Yu‐Ching Lin may publish in the future.

Co-authorship network of co-authors of Yu‐Ching Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ching Lin. A scholar is included among the top collaborators of Yu‐Ching Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ching Lin. Yu‐Ching Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Lung, Jrhau, Ming‐Szu Hung, Ting-Yao Wang, et al.. (2022). Lipid Droplets in Lung Cancers Are Crucial for the Cell Growth and Starvation Survival. International Journal of Molecular Sciences. 23(20). 12533–12533. 21 indexed citations
4.
Lin, Yu‐Ching, Li‐Chung Chiu, Shih‐Hong Li, et al.. (2022). Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study. Therapeutic Advances in Medical Oncology. 14. 4287525310–4287525310. 7 indexed citations
5.
Huang, Ethan I., Shu‐Yi Huang, Yu‐Ching Lin, et al.. (2022). Respiratory Arousals in Patients with Very Severe Obstructive Sleep Apnea and How They Change after a Non-Framework Surgery. Healthcare. 10(5). 902–902. 3 indexed citations
6.
Huang, Ethan I., et al.. (2021). Probable Change of Sleep Parameters after Resection and Reconstruction Surgeries in Patients with Oral Cavity or Oropharyngeal Cancers. BioMed Research International. 2021(1). 7408497–7408497. 4 indexed citations
8.
Lin, Gigin, Yu‐Hsiang Juan, Chao‐Hung Wang, et al.. (2020). Left Ventricular Function and Myocardial Triglyceride Content on 3T Cardiac MR Predict Major Cardiovascular Adverse Events and Readmission in Patients Hospitalized with Acute Heart Failure. Journal of Clinical Medicine. 9(1). 169–169. 11 indexed citations
9.
Huang, Ethan I., Shu‐Yi Huang, Yu‐Ching Lin, et al.. (2020). Increasing Hypopnea in Sleep Breathing Disturbance Improves Postoperative Oxygen Saturation in Patients with Very Severe Obstructive Sleep Apnea. Applied Sciences. 10(18). 6539–6539. 6 indexed citations
10.
Huang, Ethan I., Shu‐Yi Huang, Yu‐Ching Lin, et al.. (2020). A Non-Framework Multilevel Surgery May Reduce Mean Heart Rate in Patients with Very Severe Obstructive Apnea Having Confined Retroglossal Space and Framework. Applied Sciences. 10(22). 8094–8094. 3 indexed citations
11.
Lin, Yu‐Ching, et al.. (2019). Two-dimensional MEMS Fe-based metallic glass micromirror driven by an electromagnetic actuator. Japanese Journal of Applied Physics. 58(SD). SDDL01–SDDL01. 16 indexed citations
12.
Hsu, Ping‐Chih, Chun‐Chieh Wang, Chen‐Te Wu, et al.. (2019). Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study. Thoracic Cancer. 10(8). 1683–1691. 4 indexed citations
13.
Lin, Yu‐Ching, et al.. (2017). Punding following posterior cerebral artery infarction: a case report and review of literature. Neuropsychiatric Disease and Treatment. Volume 13. 981–985. 3 indexed citations
14.
Lin, Yu‐Ching, et al.. (2014). Focusing and waveguiding of Lamb waves in micro-fabricated piezoelectric phononic plates. Ultrasonics. 54(7). 1984–1990. 42 indexed citations
15.
Lien, Wei‐Chih, Nai‐Wen Guo, Jer‐Hao Chang, Yu‐Ching Lin, & Ta‐Shen Kuan. (2014). Relationship of perceived environmental barriers and disability in community-dwelling elderly in Taiwan – a population-based study. BMC Geriatrics. 14(1). 59–59. 11 indexed citations
16.
Lin, Yu‐Ching, Chin‐Kuo Lin, Kuan‐Der Lee, et al.. (2011). CK2 Inhibitors Enhance the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells Through Inhibition of Stat3 Activation. Cancer Biotherapy and Radiopharmaceuticals. 26(3). 381–388. 19 indexed citations
17.
Lin, Yu‐Ching, et al.. (2010). Comparison Between Botulinum Toxin and Corticosteroid Injection in the Treatment of Acute and Subacute Tennis Elbow. American Journal of Physical Medicine & Rehabilitation. 89(8). 653–659. 31 indexed citations
18.
Lin, Yu‐Ching, Alan Yueh‐Luen Lee, Chun‐Hua Hsu, et al.. (2010). Binding and Cleavage of E. coli HUβ by the E. coli Lon Protease. Biophysical Journal. 98(1). 129–137. 12 indexed citations
19.
Chang, Huang‐Chih, et al.. (2008). High Pathologic Complete Response in HER 2-positive Locally Advanced Breast Cancer after Primary Systemic Chemotherapy with Weekly Docetaxel and Epirubicin. Japanese Journal of Clinical Oncology. 38(2). 99–105. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026